'Ophthalmology as a segment is growing at higher rate than IPM,' Nikhil Chopra, CEO & Whole Time Director of JB Pharma says

Nikhil Chopra

linkedin.com/posts/et-healt…

Watch our CEO, Mr. Nikhil Chopra talk to CNBC about JB's future growth outlook and Q2 & H1FY24 results!!!
Nikhil Chopra CNBC Bajar

#GoodPeopleForGoodHealth #JBPharma #CNBCBajar #quarterresults #Q2FY24 #NikhilChopra

#Q2WithBQ | #JBChemicals & Pharma's stock hits 52-week high in trade on the back of strong Q2.

CEO & Whole Time Director Nikhil Chopra talks about the company's growth drivers for upcoming quarters. #BQLive JB Pharma Nikhil Chopra Alex Mathew

twitter.com/i/broadcasts/1…

Watch Mr. Nikhil Chopra, CEO & Whole Time Director, JB Pharma talk about the Q2 & H1 FY24 results. Click on the link to watch...
Nikhil Chopra CNBC-TV18

youtu.be/m_gUdySuLxU

#GoodPeopleForGoodHealth #JBPharma #CNBCTV18 #quarterresults #Q2FY24 #NikhilChopra

JB Pharma net profit rises 36% YoY in Sep quarter

#GoodPeopleforGoodHealth Nikhil Chopra

livemint.com/companies/comp…

On CNBC-TV18 | Volume growth is at 8-10% says Nikhil Chopra of JB Pharma. Tells Reema Tendulkar, Nigel D'Souza and Sonia Shenoy that they will be cash positive by the end of the year.

WATCH:
youtu.be/ThWQ_D5Alrc

Nikhil Chopra, CEO & Whole Time Director details the Q1FY24 results with ET Now. Watch to know more

Nikhil Chopra ET NOW

etnownews.com/videos/looking…

#CorporateConnection | नतीजों पर मैनेजमेंट

कैसे रहे #JBPharma के Q1 नतीजे?
घरेलू बाजार में तेजी से कितना फायदा?
FY24 के लिए क्या है ग्रोथ गाइडेंस?

देखिए कंपनी के CEO & Whole Time Director, निखिल चोपड़ा के साथ खास बातचीत

#StockMarket Nikhil Chopra Abhishek Satya Vratam

#OnCNBCTV18 | Operating #EBITDA margin will be in the range of 25-27% in next 2 years. We are looking at opportunities for inorganic #growth , says Nikhil Chopra of JB Chemicals & Pharma

medicaldialogues.in/md-brand-conne…

Amazing !!

expresspharma.in/jb-pharma-bett…

With the PRIP scheme soon coming, the partnerships of the academia with the companies can be done & roadmap can be set of what is required.: Mr. Nikhil Chopra , CEO/Whole Time Director, J.B. Chemicals & Pharmaceuticals Ltd.
FICCI
Department of Pharmaceuticals 🇮🇳
#IndiaPharma #IndiaMedicalDevice

JB Pharma expects two “sweet spots” — its contract manufacturing and India region business — to drive growth this year, according to Nikhil Chopra (Nikhil Chopra), Chief Executive and Wholetime Director with the company. Reports jyothidatta

trib.al/qiSLDbC

Good feeling of being a responsible company to spread good health globally !

The journey continues !!

This is Teams at JB who have won the award for all their effort and hard work !!Rightly so ‘Good People for Good Health’

#ScriptingEconomicChange at #ETGBS